Cart
sales@molnova.com
DHFR-IN-4
DHFR-IN-4
Catalog No. M35563
DHFR-IN-4 is a potent dihydrofolate reductase (DHFR) inhibitor with anti-tumor activity, which also inhibits EGFR and HER2, and is useful for studying pancreatic cancer.
| Size | Price / USD | Stock | Quantity |
| 5MG | 523 | In Stock |
|
| 10MG | 660 | In Stock |
|
| 25MG | 858 | In Stock |
|
| 50MG | 1144 | In Stock |
|
| 100MG | 1553 | In Stock |
|
| 200MG | 2093 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDHFR-IN-4
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Sabry MA, et al. New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity. Eur J Med Chem. 2022 Aug 10;241:114661.?
molnova catalog
related products
-
DS18561882
DS18561882 is an orally available, selective and potent inhibitor of methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) with antitumor activity, inhibits MTHFD1 activity and can be used in the study of breast cancer.
-
Fanotaprim
Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor. Fanotaprim inhibits the growth of T. gondii strains with a TgDHFR IC50 of 1.57 ± 0.11 nM and a hDHFR IC50 of 308?±?71 nM and a hDHFR to TgDHFR selectivity ratio of 196.
-
Pemetrexed Disodium ...
Pemetrexed Disodium Hydrate is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respectively.
